Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
6(35%)
Results Posted
20%(1 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_3
5
29%
Ph phase_2
3
18%
Ph phase_4
4
24%
Ph early_phase_1
1
6%
Ph not_applicable
3
18%

Phase Distribution

1

Early Stage

3

Mid Stage

9

Late Stage

Phase Distribution16 total trials
Early Phase 1First-in-human
1(6.3%)
Phase 2Efficacy & side effects
3(18.8%)
Phase 3Large-scale testing
5(31.3%)
Phase 4Post-market surveillance
4(25.0%)
N/ANon-phased studies
3(18.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

6

trials recruiting

Total Trials

17

all time

Status Distribution
Active(8)
Completed(5)
Terminated(2)
Other(2)

Detailed Status

Recruiting5
Completed5
unknown2
Not yet recruiting2
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
6
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (6.3%)
Phase 23 (18.8%)
Phase 35 (31.3%)
Phase 44 (25.0%)
N/A3 (18.8%)

Trials by Status

recruiting529%
completed529%
terminated16%
unknown212%
withdrawn16%
active_not_recruiting16%
not_yet_recruiting212%

Recent Activity

Clinical Trials (17)

Showing 17 of 17 trials
NCT07523841Not Applicable

Non-surgical Periodontitis Treatment With Aspirin and Omega-3

Active Not Recruiting
NCT07529262Phase 3

Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial

Not Yet Recruiting
NCT05557877Phase 2

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

Recruiting
NCT05198960Phase 3

AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms

Recruiting
NCT07281547Phase 4

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

Not Yet Recruiting
NCT06281665Phase 4

Treatment With Aspirin After Preeclampsia: TAP Trial

Recruiting
NCT05997693Phase 3

One-Month DAPT in CABG Patients

Recruiting
NCT04182100Phase 2

Efficacy and Safety of P1101 in Polycythemia Vera Patients for Whom the Standard of Treatment is Difficult to Apply

Completed
NCT04797949Phase 4

Adherence to Universal Aspirin Compared to Screening Indicated Aspirin for Prevention of Preeclampsia

Withdrawn
NCT05253781Phase 3

Low Dose Aspirin for Preventing Intrauterine Growth Restriction and Preeclampsia in Sickle Cell Pregnancy (PIPSICKLE)

Completed
NCT06002490Phase 3

A Study to Evaluate P1101 in Japanese PV Patients

Completed
NCT04243278Early Phase 1

Postpartum Low-Dose Aspirin After Preeclampsia for Optimization of Cardiovascular Risk (PAPVASC)

Terminated
NCT06254391Phase 2

Aspirin Dose Comparison in Elderly PCI Patients: 30mg vs. 75mg in Acute Coronary Syndrome

Recruiting
NCT04755322Not Applicable

Hydroxychloroquine in Prevention of Preeclampsia

Completed
NCT04228263Not Applicable

Hydroxychloroquine and Unexplained Recurrent Miscarriage

Completed
NCT04504864Phase 4

Low-dose Aspirin Therapy in Patients With Ischemic Stroke and Microbleeds

Unknown
NCT05089175

The Investigation of the Prediction Model and Prevention Strategy of Serious Pregnancy Complications in Hypertensive Disorders of Pregnancy Based on the Chinese Population

Unknown

All 17 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
17